InMed Pharmaceuticals Inc. Common Shares (INM)
InMed Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies derived from its core expertise in cannabinoid science. The company explores the potential medical applications of cannabinoids to treat various health conditions and aims to leverage its proprietary drug development platform to bring novel treatments to market.
Company News
The Dow Jones index closed higher by over 450 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insid...
VANCOUVER, British Columbia, Feb. 17, 2023 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced financial results for the second quarter of fiscal year 2023 which ended ...
Updates from CTMX and APLS are the key highlights from the biotech sector during the past week.
Here's what you need to know about trading penny stocks on September 2nd The post Trending Penny Stocks For Your September Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.